EPISODE · Oct 17, 2025 · 4 MIN
Trump Tariffs Squeeze EU Exports: Pharma, Steel, and Auto Industries Face Significant US Trade Barriers in 2025
from European Union Tariff News and Tracker · host Inception Point AI
Listeners, welcome back to European Union Tariff News and Tracker. Today's top stories are all about the rapidly shifting trade landscape between the United States, the Trump administration, and the European Union. Earlier this month, President Trump announced sweeping new tariffs on a wide range of imported goods, including a 100% tariff on all branded or patented pharmaceuticals produced outside the U.S., which took effect October 1. However, under a mid-2025 deal, products sourced from the European Union received a significant reprieve: EU and Japanese medicines now face a tariff capped at around 15%, while generic drugs remain exempt. This stands in sharp contrast to the 100% rate being applied to similar goods from the UK and Switzerland. The Financial Times highlighted that this partial exemption came after high-stakes negotiations—still, many European manufacturers are racing to relocate production to the U.S. or risk being squeezed out of the American pharma market. According to analysis by Bruegel, these Trump tariffs are expected to hit European Union exports, impacting about 0.2–0.3% of the EU’s overall GDP. EU leaders have stated that while new trade deals may bring modest growth, the tariff environment remains a net drag, citing specific worries about downward pressure on exports and investment decisions. Analysts at Modern Diplomacy note that turbine and machinery exports already face steep duties, and targeted relief for certain pharma categories is only partial. On industrial goods, the U.S. expanded tariffs on steel and aluminum products back in August. Forty percent of European machinery exports to the U.S. are now subject to the new duties, and business leaders across Germany’s VDMA group have voiced deep frustration to EU Trade Commissioner Maroš Šefčovič. Bertram Kawlath, VDMA President, said these tariffs directly threaten the competitiveness and survival of Europe’s advanced manufacturers, and called on the EU to urgently renegotiate exemptions. For many EU products, especially those made primarily of steel and aluminum, the effective tariff now climbs as high as 50%. Manufacturers must also document the exact raw material content to U.S. authorities—a change described by industry as bureaucratically painful, costly, and a serious market disadvantage. The result is longer delivery times and higher costs for American customers, contradicting the intended goals of U.S. reindustrialization. Meanwhile, the auto sector is bracing for a new 25% tariff on all imported medium- and heavy-duty trucks from November 1. The European Union has ramped up pressure on the U.S. to reconsider these and other tariffs on steel-containing products, arguing that the duties unfairly penalize downstream industries and fracture transatlantic supply chains. Looking forward, the Trump administration is signaling that these tariffs and related investigations—covering everything from robotics to industrial machinery—may extend even further, inject This content was created in partnership and with the help of Artificial Intelligence AI.
What this episode covers
Listeners, welcome back to European Union Tariff News and Tracker. Today's top stories are all about the rapidly shifting trade landscape between the United States, the Trump administration, and the European Union. Earlier this month, President Trump announced sweeping new tariffs on a wide range of imported goods, including a 100% tariff on all branded or patented pharmaceuticals produced outside the U.S., which took effect October 1. However, under a mid-2025 deal, products sourced from the European Union received a significant reprieve: EU and Japanese medicines now face a tariff capped at around 15%, while generic drugs remain exempt. This stands in sharp contrast to the 100% rate being applied to similar goods from the UK and Switzerland. The Financial Times highlighted that this partial exemption came after high-stakes negotiations—still, many European manufacturers are racing to relocate production to the U.S. or risk being squeezed out of the American pharma market. According to analysis by Bruegel, these Trump tariffs are expected to hit European Union exports, impacting about 0.2–0.3% of the EU’s overall GDP. EU leaders have stated that while new trade deals may bring modest growth, the tariff environment remains a net drag, citing specific worries about downward pressure on exports and investment decisions. Analysts at Modern Diplomacy note that turbine and machinery exports already face steep duties, and targeted relief for certain pharma categories is only partial. On industrial goods, the U.S. expanded tariffs on steel and aluminum products back in August. Forty percent of European machinery exports to the U.S. are now subject to the new duties, and business leaders across Germany’s VDMA group have voiced deep frustration to EU Trade Commissioner Maroš Šefčovič. Bertram Kawlath, VDMA President, said these tariffs directly threaten the competitiveness and survival of Europe’s advanced manufacturers, and called on the EU to urgently renegotiate exemptions. For many EU products, especially those made primarily of steel and aluminum, the effective tariff now climbs as high as 50%. Manufacturers must also document the exact raw material content to U.S. authorities—a change described by industry as bureaucratically painful, costly, and a serious market disadvantage. The result is longer delivery times and higher costs for American customers, contradicting the intended goals of U.S. reindustrialization. Meanwhile, the auto sector is bracing for a new 25% tariff on all imported medium- and heavy-duty trucks from November 1. The European Union has ramped up pressure on the U.S. to reconsider these and other tariffs on steel-containing products, arguing that the duties unfairly penalize downstream industries and fracture transatlantic supply chains. Looking forward, the Trump administration is signaling that these tariffs and related investigations—covering everything from robotics to industrial machinery—may extend even further, inject This content was created in partnership and with the help of Artificial Intelligence AI.
NOW PLAYING
Trump Tariffs Squeeze EU Exports: Pharma, Steel, and Auto Industries Face Significant US Trade Barriers in 2025
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m